» Articles » PMID: 24101058

Substantial Health and Economic Returns from Delayed Aging May Warrant a New Focus for Medical Research

Overview
Specialty Health Services
Date 2013 Oct 9
PMID 24101058
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Recent scientific advances suggest that slowing the aging process (senescence) is now a realistic goal. Yet most medical research remains focused on combating individual diseases. Using the Future Elderly Model--a microsimulation of the future health and spending of older Americans--we compared optimistic "disease specific" scenarios with a hypothetical "delayed aging" scenario in terms of the scenarios' impact on longevity, disability, and major entitlement program costs. Delayed aging could increase life expectancy by an additional 2.2 years, most of which would be spent in good health. The economic value of delayed aging is estimated to be $7.1 trillion over fifty years. In contrast, addressing heart disease and cancer separately would yield diminishing improvements in health and longevity by 2060--mainly due to competing risks. Delayed aging would greatly increase entitlement outlays, especially for Social Security. However, these changes could be offset by increasing the Medicare eligibility age and the normal retirement age for Social Security. Overall, greater investment in research to delay aging appears to be a highly efficient way to forestall disease, extend healthy life, and improve public health.

Citing Articles

Selecting Appropriate Clinical Trial Endpoints for Geroscience Trials: A Path Towards Consensus.

Kritchevsky S, Zamora E, Bhasin S, Cohen A, Chandler A, Covinsky K Res Sq. 2025; .

PMID: 39989956 PMC: 11844647. DOI: 10.21203/rs.3.rs-5920485/v1.


Multi-dimensional evidence from the UK Biobank shows the impact of diet and macronutrient intake on aging.

Zhu C, Wang Y, Yang X, Zhao Q, Xu W, Wang X Commun Med (Lond). 2025; 5(1):36.

PMID: 39905241 PMC: 11794871. DOI: 10.1038/s43856-025-00754-5.


Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial.

Bischoff-Ferrari H, Gangler S, Wieczorek M, Belsky D, Ryan J, Kressig R Nat Aging. 2025; .

PMID: 39900648 DOI: 10.1038/s43587-024-00793-y.


The Role of Quercetin, a Flavonoid in the Management of Pathogenesis Through Regulation of Oxidative Stress, Inflammation, and Biological Activities.

Alharbi H, Alshebremi M, Babiker A, Rahmani A Biomolecules. 2025; 15(1).

PMID: 39858545 PMC: 11763763. DOI: 10.3390/biom15010151.


Exploring the value and optimizing strategies of CA125, CA199, CEA, AFP, and PT in predicting adenomatous gastrointestinal polyps in elderly male patients.

Zhou J, Li Q, Rao C Medicine (Baltimore). 2024; 103(49):e40366.

PMID: 39654213 PMC: 11630973. DOI: 10.1097/MD.0000000000040366.


References
1.
Harrison D, Strong R, Sharp Z, Nelson J, Astle C, Flurkey K . Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392-5. PMC: 2786175. DOI: 10.1038/nature08221. View

2.
Lipton R, Hirsch J, Katz M, Wang C, Sanders A, Verghese J . Exceptional parental longevity associated with lower risk of Alzheimer's disease and memory decline. J Am Geriatr Soc. 2010; 58(6):1043-9. PMC: 2950109. DOI: 10.1111/j.1532-5415.2010.02868.x. View

3.
Fries J . Aging, natural death, and the compression of morbidity. N Engl J Med. 1980; 303(3):130-5. DOI: 10.1056/NEJM198007173030304. View

4.
Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

5.
Fries J, KOOP C, Beadle C, Cooper P, ENGLAND M, Greaves R . Reducing health care costs by reducing the need and demand for medical services. The Health Project Consortium. N Engl J Med. 1993; 329(5):321-5. DOI: 10.1056/NEJM199307293290506. View